[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,191,552
  • Shares Outstanding, K 156,569
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 73,400 K
  • EBIT $ 154 M
  • EBITDA $ 264 M
  • 60-Month Beta 1.29
  • Price/Sales 9.26
  • Price/Cash Flow 29.14
  • Price/Book 5.35

Options Overview Details

View History
  • Implied Volatility 9.40% (-2.84%)
  • Historical Volatility 60.58%
  • IV Percentile 5%
  • IV Rank 6.97%
  • IV High 63.80% on 04/29/26
  • IV Low 5.32% on 07/07/26
  • Expected Move (DTE 36) 1.73 (2.40%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7,581
  • Volume Avg (30-Day) 2,582
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 35,724
  • Open Int (30-Day) 23,532
  • Expected Range 70.04 to 73.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.46
  • Number of Estimates 5
  • High Estimate $0.49
  • Low Estimate $0.41
  • Prior Year $0.51
  • Growth Rate Est. (year over year) -9.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.32 +32.12%
on 06/17/26
71.81 -0.06%
on 07/16/26
+15.74 (+28.09%)
since 06/16/26
3-Month
43.19 +66.15%
on 05/15/26
71.81 -0.06%
on 07/16/26
+14.41 (+25.12%)
since 04/16/26
52-Week
43.19 +66.15%
on 05/15/26
72.16 -0.54%
on 01/22/26
+19.98 (+38.58%)
since 07/16/25

Most Recent Stories

More News
Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks

Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks

TECH : 71.77 (+0.41%)
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

Advancing Scalable Reproducible Cell Therapy and Advanced Cell Culture Workflows

TECH : 71.77 (+0.41%)
Are SYNA, IRDM, TECH, PATK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

IRDM : 46.61 (-4.23%)
TECH : 71.77 (+0.41%)
PATK : 88.25 (+4.31%)
SYNA : 115.55 (-4.97%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA

NEW YORK , July 2, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

NDRA : 5.27 (-6.06%)
TECH : 71.77 (+0.41%)
FSRL : 19.2100 (+2.62%)
SYNA : 115.55 (-4.97%)
Bio-Techne Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bio-Techne Corporation - TECH

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Bio-Techne Corporation...

TECH : 71.77 (+0.41%)
Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

IRDM : 46.61 (-4.23%)
TBPH : 16.97 (+0.24%)
TECH : 71.77 (+0.41%)
SYNA : 115.55 (-4.97%)
1 Momentum Stock with Impressive Fundamentals and 2 We Find Risky

1 Momentum Stock with Impressive Fundamentals and 2 We Find Risky

TECH : 71.77 (+0.41%)
AMN : 34.22 (+5.78%)
WWD : 394.12 (-1.96%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH)

NEW YORK , June 26, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

TECH : 71.77 (+0.41%)
The $11 Billion Reason TECH Stock Is Up Today

Bio-Techne stock rallies as Merck announces an agreement to acquire it for $73 per share. But is there any further upside left in TECH shares?

TECH : 71.77 (+0.41%)
MKKGY : 31.6100 (-1.98%)
Stock Index Futures Slip as Chip Selloff Resumes, Fed Speak on Tap

September S&P 500 E-Mini futures (ESU26) are down -0.51%, and September Nasdaq 100 E-Mini futures (NQU26) are down -1.18% this morning as renewed selling pressure hit the tech sector, with chipmakers leading...

AAPL : 333.26 (+1.76%)
SNDK : 1,411.08 (-12.63%)
FCEL : 17.26 (-14.77%)
NQU26 : 29,022.75 (-0.69%)
MU : 853.20 (-5.65%)
ORCL : 124.21 (-6.25%)
NKE : 44.57 (+4.21%)
TECH : 71.77 (+0.41%)
ZAL.D.DX : 27.730 (-0.50%)
CRWV : 72.91 (-5.46%)
QCOM : 170.61 (-4.14%)
WDC : 466.81 (-9.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 72.26
2nd Resistance Point 72.04
1st Resistance Point 71.90
Last Price 71.77
1st Support Level 71.54
2nd Support Level 71.32
3rd Support Level 71.18

See More

52-Week High 72.16
Last Price 71.77
Fibonacci 61.8% 61.10
Fibonacci 50% 57.68
Fibonacci 38.2% 54.26
52-Week Low 43.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.